The combined vaccine elicited higher immune response against SARS-CoV-2.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
"The message is be prepared for a bad flu season on top of a bad COVID season," says Edward Belongia, MD.
A large observational study showed some promise, but 2 randomized clinical trials did not.
The CDC now recommends mask wearing on airplanes, trains, subways, buses, taxis, and other ride-share vehicles.
Racial and ethnic minority workers have been disproportionately affected by COVID-19 in food manufacturing and agriculture workplaces, according to a study yesterday in Emerging Infectious Diseases.
Demographics were not available for all 742 sites surveyed across 30 states, but for those that were, 83.2% of confirmed cases involved minorities even though they made up only 47.4% of all workers.
"The virus has shown that, when we let our guard down, it can surge back at breakneck speed and threaten hospitals and health systems."
A randomized, controlled clinical trial involving high-risk healthcare workers found that pre-exposure prophylaxis with hydroxychloroquine once or twice weekly did not significantly reduce COVID-19 compared with placebo, researchers reported late last week in Clinical Infectious Diseases.
The death rate was high in patients with chronic kidney disease and in those who developed kidney injury in the ICU.
The emergency sick leave provision of the Mar 18 bipartisan Families First Coronavirus Response Act (FFCRA) appears to have reduced the spread of the virus. A Health Affairs study yesterday found that states where workers could get up to 2 weeks of paid sick leave showed 417 fewer confirmed cases per day, or an average of 1 prevented case per day per 1,300 workers.
In some states, like Wisconsin, hospitals are strained; also, Pfizer says its vaccine will be delayed.
As the next steps, officials will conduct a meta-analysis of remdesivir studies, which experts will use to guide treatment advice.
